Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: A histomorphometric study

This publication has 25 references indexed in Scilit:

• Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate
  Bone, 1988
• Effects of intravenous etidronate disodium on skeletal and calcium metabolism
  The American Journal of Medicine, 1987
• Etidronate disodium in the management of malignancy-related hypercalcemia
  The American Journal of Medicine, 1987
• COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIA
  The Lancet, 1985
• The Hypercalcemia of Cancer
  New England Journal of Medicine, 1984
• Use of Dichloromethylene Diphosphonate in Metastatic Bone Disease
  New England Journal of Medicine, 1983
• Effect of Calcitonin and Glucocorticoids in Combination on the Hypercalcemia of Malignancy
  Annals of Internal Medicine, 1980
• EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASE
  The Lancet, 1980
• Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
  Journal of Clinical Investigation, 1980
• INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)
  The Lancet, 1979